TAK-243 | Interleukin Related interleukin-related.com

Product Name :
TAK-243

Search keywords :
TAK-243

drugId :
null

Target Vo:
Ubiquitin-like modifier-activating enzyme 1

Target Vo Short Name :
UBA1

Moa_Name:
Ubiquitin-like modifier-activating enzyme 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Takeda Pharmaceutical Co Ltd

Active Company_Name :
National Cancer Institute

Active Indication_Name:
Lymphoma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Toll-Like Receptor 4 Antibody
GSDMD Antibody
Glucose 6 Phosphate Dehydrogenase Antibody: Glucose 6 Phosphate Dehydrogenase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa, targeting to Glucose 6 Phosphate Dehydrogenase. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts